Evidence map›Paper›PMID 24915161›Full record

ArticleNature communications2014

Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs.

Xiufeng Zhong, Christian Gutierrez, Tian Xue, Christopher Hampton, M Natalia Vergara, Li-Hui Cao, Ann Peters, Tea Soon Park, Elias T Zambidis, Jason S Meyer and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 606 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
606citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

606 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Neuroinflammation in glaucoma: a myriad of cellular pathways and players.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Review
  18. Personalized Pathogenicity Assessment ofInternational journal of molecular sciences · 2026
    Article
  19. Article
  20. Article

546 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiufeng ZhongWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Christian GutierrezWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Tian Xue1] School of Life Sciences and Hefei National Laboratory for Physical Sciences at Microscale, University of Science and Technology of China, Hefei 230026, China [2] Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Christopher HamptonWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
M Natalia VergaraWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Li-Hui Cao1] Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA [2].
Ann PetersInstitute for Cell Engineering and Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.
Tea Soon ParkInstitute for Cell Engineering and Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.
Elias T ZambidisInstitute for Cell Engineering and Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA.
Jason S MeyerDepartment of Biology, Department of Medical and Molecular Genetics, and Stark Neuroscience Research Institute, Indiana University-Purdue University, Indianapolis, Indiana 46202, USA.
David M GammDepartment of Ophthalmology and Visual Sciences, McPherson Eye Research Institute and Waisman Center Stem Cell Research Program, University of Wisconsin, Madison, Wisconsin 53705, USA.
King-Wai Yau1] Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA [2] Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
M Valeria Canto-SolerWilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.

Funding

Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI Jiang Qian · 1985 to 2026
$22.1M
VISUAL TRANSDUCTION IN RETINAL PHOTORECEPTORSR01EY006837 · NEI · JOHNS HOPKINS UNIVERSITY · PI KING-WAI YAU · 1987 to 2026
$8.5M
Basic and Translational Research of iPSC-Based hematologic and Vascular TherapiesU01HL099775 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI FRIEDMAN, ALAN D · 2009 to 2015
$8.4M
Mechanisms of Retinogenesis in Human Stem CellsR01EY021218 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI GAMM, DAVID M · 2010 to 2017
$2.2M
Mechanisms of retinal cell differentiationR01EY022631 · NEI · UNIVERSITY OF COLORADO DENVER · PI CANTO-SOLER, MARIA VALERIA · 2012 to 2016
$2.0M
Pluripotent Stem Cell Vascular Therapies for Ischemic RetinopathiesR01EY023962 · NEI · JOHNS HOPKINS UNIVERSITY · PI ZAMBIDIS, ELIAS T. · 2014 to 2018
$1.8M
Transcriptional and Epigenetic Regulation of HSC Generated from iPS and ESCR03HL096220 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI FRIEDMAN, ALAN D, ZAMBIDIS, ELIAS T. · 2009 to 2009
$41k
NEI NIH HHS EY022631NEI NIH HHS EY1765NEI NIH HHS P30 EY001765NEI NIH HHS R01 EY006837NEI NIH HHS R01 EY021218NEI NIH HHS R01EY021218NEI NIH HHS R01 EY022631NEI NIH HHS R01 EY023962NEI NIH HHS R01EY06837NHLBI NIH HHS R03 HL096220NHLBI NIH HHS U01 HL099775NHLBI NIH HHS U01HL099775
6 · The paper itself

Abstract

Many forms of blindness result from the dysfunction or loss of retinal photoreceptors. Induced pluripotent stem cells (iPSCs) hold great potential for the modelling of these diseases or as potential therapeutic agents. However, to fulfill this promise, a remaining challenge is to induce human iPSC to recreate in vitro key structural and functional features of the native retina, in particular the presence of photoreceptors with outer-segment discs and light sensitivity. Here we report that hiPSC can, in a highly autonomous manner, recapitulate spatiotemporally each of the main steps of retinal development observed in vivo and form three-dimensional retinal cups that contain all major retinal cell types arranged in their proper layers. Moreover, the photoreceptors in our hiPSC-derived retinal tissue achieve advanced maturation, showing the beginning of outer-segment disc formation and photosensitivity. This success brings us one step closer to the anticipated use of hiPSC for disease modelling and open possibilities for future therapies.

Indexed as

Cell DifferentiationCell LineHumansInduced Pluripotent Stem CellsPhotoreceptor Cells, VertebrateRetina

Identifiers

PMID24915161
PMCPMC4370190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.